My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 2331

    1.

    Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs.

    Aloysius MM, Mc Kechnie AJ, Robins RA, Verma C, Eremin JM, Farzaneh F, Habib NA, Bhalla J, Hardwick NR, Satthaporn S, Sreenivasan T, El-Sheemy M, Eremin O.

    J Transl Med. 2009 Mar 19;7:18.PMID: 19298672 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    2.

    In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.

    Goddard RV, Prentice AG, Copplestone JA, Kaminski ER.

    Clin Exp Immunol. 2003 Jan;131(1):82-9.PMID: 12519390 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    3.

    Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.

    Santodonato L, D'Agostino G, Nisini R, Mariotti S, Monque DM, Spada M, Lattanzi L, Perrone MP, Andreotti M, Belardelli F, Ferrantini M.

    J Immunol. 2003 May 15;170(10):5195-202.PMID: 12734367 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    4.

    Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor.

    Baxevanis CN, Voutsas IF, Tsitsilonis OE, Gritzapis AD, Sotiriadou R, Papamichail M.

    J Immunol. 2000 Apr 1;164(7):3902-12.PMID: 10725753 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    5.

    Dendritic cell gene therapy.

    Onaitis M, Kalady MF, Pruitt S, Tyler DS.

    Surg Oncol Clin N Am. 2002 Jul;11(3):645-60. Review.PMID: 12487060 [PubMed - indexed for MEDLINE]Related citations

    6.

    Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

    Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

    Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.PMID: 15146294 [PubMed - indexed for MEDLINE]Related citations

    7.

    Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.

    de Vries IJ, Lesterhuis WJ, Scharenborg NM, Engelen LP, Ruiter DJ, Gerritsen MJ, Croockewit S, Britten CM, Torensma R, Adema GJ, Figdor CG, Punt CJ.

    Clin Cancer Res. 2003 Nov 1;9(14):5091-100.PMID: 14613986 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    8.

    Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells.

    Carbonneil C, Aouba A, Burgard M, Cardinaud S, Rouzioux C, Langlade-Demoyen P, Weiss L.

    AIDS. 2003 Aug 15;17(12):1731-40.PMID: 12891059 [PubMed - indexed for MEDLINE]Related citations

    9.

    Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells.

    Babatz J, Röllig C, Löbel B, Folprecht G, Haack M, Günther H, Köhne CH, Ehninger G, Schmitz M, Bornhäuser M.

    Cancer Immunol Immunother. 2006 Mar;55(3):268-76. Epub 2005 Jul 21.PMID: 16034561 [PubMed - indexed for MEDLINE]Related citations

    10.

    Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen.

    Itoh T, Ueda Y, Kawashima I, Nukaya I, Fujiwara H, Fuji N, Yamashita T, Yoshimura T, Okugawa K, Iwasaki T, Ideno M, Takesako K, Mitsuhashi M, Orita K, Yamagishi H.

    Cancer Immunol Immunother. 2002 Apr;51(2):99-106. Epub 2002 Jan 30.PMID: 11904734 [PubMed - indexed for MEDLINE]Related citations

    11.

    [Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer]

    You J, Yu JP, Ren XB, Wang CL, Zhang P, Zhang XZ.

    Zhonghua Zhong Liu Za Zhi. 2004 Jun;26(6):333-6. Chinese. PMID: 15312341 [PubMed - indexed for MEDLINE]Related citations

    12.

    Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.

    Kokhaei P, Palma M, Hansson L, Osterborg A, Mellstedt H, Choudhury A.

    Exp Hematol. 2007 Feb;35(2):297-304.PMID: 17258078 [PubMed - indexed for MEDLINE]Related citations

    13.

    Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.

    Bohnenkamp HR, Coleman J, Burchell JM, Taylor-Papadimitriou J, Noll T.

    Cell Immunol. 2004 Sep-Oct;231(1-2):112-25. Epub 2005 Feb 8.PMID: 15919376 [PubMed - indexed for MEDLINE]Related citations

    14.

    Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.

    Schnurr M, Galambos P, Scholz C, Then F, Dauer M, Endres S, Eigler A.

    Cancer Res. 2001 Sep 1;61(17):6445-50.PMID: 11522639 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    15.

    A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

    Jonuleit H, Giesecke-Tuettenberg A, Tüting T, Thurner-Schuler B, Stuge TB, Paragnik L, Kandemir A, Lee PP, Schuler G, Knop J, Enk AH.

    Int J Cancer. 2001 Jul 15;93(2):243-51.PMID: 11410873 [PubMed - indexed for MEDLINE]Related citations

    16.

    Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses.

    Herr W, Ranieri E, Olson W, Zarour H, Gesualdo L, Storkus WJ.

    Blood. 2000 Sep 1;96(5):1857-64.PMID: 10961887 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    17.

    Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.

    Vonderheide RH, Domchek SM, Schultze JL, George DJ, Hoar KM, Chen DY, Stephans KF, Masutomi K, Loda M, Xia Z, Anderson KS, Hahn WC, Nadler LM.

    Clin Cancer Res. 2004 Feb 1;10(3):828-39.PMID: 14871958 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    18.

    Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.

    Larsson M, Messmer D, Somersan S, Fonteneau JF, Donahoe SM, Lee M, Dunbar PR, Cerundolo V, Julkunen I, Nixon DF, Bhardwaj N.

    J Immunol. 2000 Aug 1;165(3):1182-90.PMID: 10903715 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    19.

    Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses.

    Adotévi O, Mollier K, Neuveut C, Cardinaud S, Boulanger E, Mignen B, Fridman WH, Zanetti M, Charneau P, Tartour E, Lemonnier F, Langlade-Demoyen P.

    Clin Cancer Res. 2006 May 15;12(10):3158-67.PMID: 16707616 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    20.

    Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.

    Curti A, Isidori A, Ferri E, Terragna C, Neyroz P, Cellini C, Ratta M, Baccarani M, Lemoli RM.

    Leuk Lymphoma. 2004 Jul;45(7):1419-28.PMID: 15359643 [PubMed - indexed for MEDLINE]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk